Literature DB >> 20004151

Constipation in pediatric cystic fibrosis patients: an underestimated medical condition.

H P J van der Doef1, F T M Kokke, F J A Beek, J W Woestenenk, S P Froeling, R H J Houwen.   

Abstract

BACKGROUND: The aims of this study were to determine prevalence, risk factors and treatment of constipation in patients with Cystic Fibrosis (CF), as well as the diagnostic value of abdominal radiography.
METHODS: A cohort of 214 pediatric CF patients was investigated. Furthermore, 106 abdominal radiographs of CF patients with or without constipation were independently assessed by three observers on two separate occasions using the Barr and Leech scores.
RESULTS: The prevalence of constipation was 47%. Low total fat absorption and meconium ileus were independent risk factors for constipation in CF, while fiber and fluid intake were not associated. In CF patients the inter and intraobserver variabilities of the Barr and Leech scores were poor to moderate.
CONCLUSION: Constipation is a significant medical issue in CF and was associated with low total fat absorption and a history of meconium ileus. Finally, abdominal radiography seems of little value in the regular follow-up of CF patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004151     DOI: 10.1016/j.jcf.2009.11.003

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  16 in total

Review 1.  Beyond pancreatic insufficiency and liver disease in cystic fibrosis.

Authors:  Stephanie Demeyer; Kris De Boeck; Peter Witters; Katrien Cosaert
Journal:  Eur J Pediatr       Date:  2016-04-07       Impact factor: 3.183

2.  Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: a questionnaire survey.

Authors:  Rebecca Chambers; Adam Lucht; Aisling Reihill; Judith Hough
Journal:  Int Urogynecol J       Date:  2016-10-13       Impact factor: 2.894

Review 3.  Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.

Authors:  Alicia K Olivier; Katherine N Gibson-Corley; David K Meyerholz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

Review 4.  Luminal Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Samuel J Burton; Christine Hachem; James M Abraham
Journal:  Curr Gastroenterol Rep       Date:  2021-03-23

Review 5.  Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Authors:  Will Carroll; Jessica Green; Francis J Gilchrist
Journal:  Cochrane Database Syst Rev       Date:  2021-12-22

6.  Lubiprostone is non-selective activator of cAMP-gated ion channels and Clc-2 has a minor role in its prosecretory effect in intestinal epithelial cells.

Authors:  Apurva A Oak; Tifany Chu; Pattareeya Yottasan; Parth D Chhetri; Jie Zhu; Justin Du Bois; Onur Cil
Journal:  Mol Pharmacol       Date:  2022-06-09       Impact factor: 4.054

7.  Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.

Authors:  Drucy Borowitz; Barry Lubarsky; Michael Wilschanski; Anne Munck; Daniel Gelfond; Frank Bodewes; Sarah Jane Schwarzenberg
Journal:  Dig Dis Sci       Date:  2015-08-07       Impact factor: 3.199

Review 8.  The cystic fibrosis intestine.

Authors:  Robert C De Lisle; Drucy Borowitz
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 9.  Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation.

Authors:  Hubert P J van der Doef; Freddy T M Kokke; Cornelis K van der Ent; Roderick H J Houwen
Journal:  Curr Gastroenterol Rep       Date:  2011-06

10.  SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine.

Authors:  Onur Cil; Peter M Haggie; Joseph-Anthony Tapia Tan; Amber A Rivera; Alan S Verkman
Journal:  JCI Insight       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.